A

Aveo Pharmaceuticals Inc
F:VPA1

Watchlist Manager
Aveo Pharmaceuticals Inc
F:VPA1
Watchlist
Price: 13.77 EUR -0.4% Market Closed
Market Cap: 478.7m EUR

Wall Street
Price Targets

VPA1 Price Targets Summary
Aveo Pharmaceuticals Inc

There are no price targets for VPA1.
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
Aveo Pharmaceuticals Inc Competitors:
Price Targets
VIR
Vir Biotechnology Inc
247% Upside
GLUE
Monte Rosa Therapeutics Inc
241% Upside
688428
InnoCare Pharma Ltd
8% Downside
BSLN
Basilea Pharmaceutica AG
92% Upside
CPRX
Catalyst Pharmaceuticals Inc
62% Upside
ASND
Ascendis Pharma A/S
31% Upside
LGND
Ligand Pharmaceuticals Inc
28% Upside
MRNA
Moderna Inc
57% Upside

Revenue
Forecast

Revenue Estimate
Aveo Pharmaceuticals Inc

For the last 8 years the compound annual growth rate for Aveo Pharmaceuticals Inc's revenue is 55%. The projected CAGR for the next 1 year is 208%.

55%
Past Growth
208%
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

Operating Income
Forecast

Operating Income Estimate
Aveo Pharmaceuticals Inc

Operating Income forecast
is not available for
Aveo Pharmaceuticals Inc

Net Income
Forecast

Net Income Estimate
Aveo Pharmaceuticals Inc

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is VPA1's stock price target?
Not Available

VPA1 doesn't have any price targets made by Wall Street professionals.

What is Aveo Pharmaceuticals Inc's Revenue forecast?
Projected CAGR
208%

For the last 8 years the compound annual growth rate for Aveo Pharmaceuticals Inc's revenue is 55%. The projected CAGR for the next 1 year is 208%.

Back to Top